HOME >> BIOLOGY >> NEWS
UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment

(Santa Barbara, Calif.) The University of California, Santa Barbara announced today that it has donated all rights to a patent that covers the novel use of an established class of cardiovascular medicines as a potential new drug against a global parasitic disease. The Institute for OneWorld Health, a nonprofit pharmaceutical company based in San Francisco, will use the UCSB discovery and the wealth of data associated with the medicines to accelerate drug development for treatment of schistosomiasis.

Two UCSB researchers discovered that calcium channel blockers may prove to be an inexpensive alternative for controlling schistosome infection, a serious global health problem that afflicts more than 200 million people annually in developing nations. An estimated 200,000 people, many of them older children, die every year from schistosomiasis. Many more suffer chronic damage to vital organs, including the liver and bladder.

The inventors are Mark Walter, a research biologist, and Armand Kuris, professor of biology.

"Calcium channel blockers look very promising for the treatment of schistosomiasis, which is a devastating disease," said Kuris, an expert in parasitology and associate provost of the College of Creative Studies. Physicians routinely prescribe calcium channel blockers to treat high blood pressure, correct abnormal heart rhythms, treat panic attacks and bipolar disorder, and prevent migraine headaches.

"We know that the drugs are safe for people," said Kuris. "They are available, and not terribly expensive. For a tropical disease that is very, very important. We are gratified by OneWorld Health's interest in our discovery, and confident in its ability to develop this inexpensive treatment for schistosomiasis for children in rural villages throughout the world."

OneWorld Health partners with pharmaceutical and biotechnology companies, universities, government agencies, and global health advocates to develop comp
'"/>


24-Feb-2004


Page: 1 2 3

Related biology news :

1. UC Santa Barbara discovers cell survival gene may lead to treatments for degenerative diseases
2. Chemical society convenes regional meeting in Santa Barbara, October 28-31
3. Webcast will ensure broad public access to the UC Santa Cruz Public Forum on Human Genome Research
4. UC Santa Cruz Public Forum on the Human Genome
5. Coastal research project at UC Santa Cruz receives major boost in funding
6. UC Davis, Santa Barbara get $6 million to help estuaries
7. Future uses of MicroElectricalMechanical (MEM) systems to be featured at Santa Clara show
8. USGS Scientists To Speak On Rare Plants And Invasive Species At Santa Barbara Symposium
9. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
10. Dupont donates patents to UCSD
11. Procter & Gamble donates proprietary "super aspirin" technology to Vanderbilt University

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its ... public health agencies of all sizes. With a focus on tracking symptoms and ... appropriate health care, Mosio helps public health departments automate communications and provide more ...
(Date:7/31/2020)... FREDERICK, Md. (PRWEB) , ... July 30, 2020 ... ... Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & ... goal of this project is to develop, optimize, and scale-up a highly efficient ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, ... need a comparability study, but what is the most effective way to complete ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... CAMBRIDGE, Mass. and SOMERSET, N.J (PRWEB) , ... ... ... a leading genome editing company, and Catalent, the leading global provider of advanced ... and consumer health products, today announced that they have entered into a strategic ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... software for the life sciences industry, today announced the release of its ... specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... and products, announces a significant expansion of laboratory operations through its COVID-19 ... agencies implementing testing programs. , Bode-CARES provides a turnkey solution ...
Breaking Biology Technology:
Cached News: